off-label use

The clinical use of an FDA-approved drug, device or biologic for a purpose or population that has not been approved by the FDA, or in a route or dose that has not be approved by the FDA. Off-label use is not regulated by the IRB or the FDA; it is subject only to any policies and procedures of the clinician’s institution.